Cambridge Healthtech Institute’s Inaugural

Immunotherapy for COVID-19

Vaccine and Biotherapeutic Development for SARS-CoV-2

October 8, 2020

In response to the urgent need for vaccines and biotherapeutics for the novel coronavirus, Cambridge Healthtech Institute is adding a new track dedicated to COVID-19 to our Immuno-Oncology Summit that aims to facilitate innovation and collaboration in immunotherapy approaches to control the cytokine storm, develop novel antibody biotherapeutics and vaccines, and understand the immune response mechanisms.